Search Results - "HOLCZBAUER, Agnes"

Refine Results
  1. 1

    MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities by Sequera, Celia, Grattarola, Margherita, Holczbauer, Agnes, Dono, Rosanna, Pizzimenti, Stefania, Barrera, Giuseppina, Wangensteen, Kirk J., Maina, Flavio

    Published in Cell death & disease (24-11-2022)
    “…Enhanced activation of the transcription factor MYC and of the receptor tyrosine kinase MET are among the events frequently occurring in hepatocellular…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling by Kitade, Mitsuteru, Factor, Valentina M, Andersen, Jesper B, Tomokuni, Akira, Kaji, Kosuke, Akita, Hirofumi, Holczbauer, Agnes, Seo, Daekwan, Marquardt, Jens U, Conner, Elizabeth A, Lee, Seung-Bum, Lee, Yun-Han, Thorgeirsson, Snorri S

    Published in Genes & development (01-08-2013)
    “…The relative contribution of hepatocyte growth factor (HGF)/MET and epidermal growth factor (EGF)/EGF receptor (EGFR), two key signal transduction systems in…”
    Get full text
    Journal Article
  4. 4

    Distinct Claudin Expression Profiles of Hepatocellular Carcinoma and Metastatic Colorectal and Pancreatic Carcinomas by Holczbauer, Ágnes, Gyöngyösi, Benedek, Lotz, Gábor, Szijártó, Attila, Kupcsulik, Péter, Schaff, Zsuzsa, Kiss, András

    “…Tight junction proteins, including claudins, are often dysregulated during carcinogenesis and tumor progression. Moreover, the claudin expression pattern…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Contribution of Hepatic Lineage Stage-Specific Donor Memory to the Differential Potential of Induced Mouse Pluripotent Stem Cells by Lee, Seung Bum, Seo, Daekwan, Choi, Dongho, Park, Kye-Yoon, Holczbauer, Agnes, Marquardt, Jens U., Conner, Elizabeth A., Factor, Valentina M., Thorgeirsson, Snorri S.

    Published in Stem cells (Dayton, Ohio) (01-05-2012)
    “…Recent studies suggested that induced pluripotent stem cells (iPSCs) retain a residual donor cell gene expression, which may impact their capacity to…”
    Get full text
    Journal Article
  7. 7

    Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma by Halász, Judit, Holczbauer, Ágnes, Páska, Csilla, Kovács, Margit, Benyó, Gábor, Verebély, Tibor, Schaff, Zsuzsa, Kiss, András

    Published in Human pathology (01-05-2006)
    “…Claudins (CLDNs), a family of transmembrane proteins, are major constituents of tight junctions (TJs). They have been shown to be differentially regulated in…”
    Get full text
    Journal Article
  8. 8

    Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types by Holczbauer, Ágnes, Factor, Valentina M, Andersen, Jesper B, Marquardt, Jens U, Kleiner, David E, Raggi, Chiara, Kitade, Mitsuteru, Seo, Daekwan, Akita, Hirofumi, Durkin, Marian E, Thorgeirsson, Snorri S

    Published in Gastroenterology (New York, N.Y. 1943) (01-07-2013)
    “…Background & Aims Human primary liver cancer is classified into biologically distinct subgroups based on cellular origin. Liver cancer stem cells (CSCs) have…”
    Get full text
    Journal Article
  9. 9

    Claudin expression in Barrett's esophagus and adenocarcinoma by Gyõrffy, Hajnalka, Holczbauer, Agnes, Nagy, Pál, Szabó, Zsuzsa, Kupcsulik, Péter, Páska, Csilla, Papp, János, Schaff, Zsuzsa, Kiss, András

    “…Claudins (CLDNs) are key molecules in cell adhesion, polarity, and control of paracellular solute transport. Several studies suggested that changes in claudin…”
    Get full text
    Journal Article
  10. 10

    Cellular origins of regenerating liver and hepatocellular carcinoma by Holczbauer, Ágnes, Wangensteen, Kirk J., Shin, Soona

    Published in JHEP reports (01-04-2022)
    “…Hepatocellular carcinoma (HCC) is the predominant primary cancer arising from the liver and is one of the major causes of cancer-related mortality worldwide…”
    Get full text
    Journal Article
  11. 11

    Expression of Matrilin-2 in Liver Cirrhosis and Hepatocellular Carcinoma by Szabó, Erzsébet, Korpos, Éva, Batmunkh, Enkhjargal, Lotz, Gábor, Holczbauer, Ágnes, Kovalszky, Ilona, Deák, Ferenc, Kiss, Ibolya, Schaff, Zsuzsa, Kiss, András

    Published in Pathology oncology research (01-03-2008)
    “…The recently described matrilin protein family is part of the extracellular matrix, their pathophysiological role as well as distribution in liver diseases,…”
    Get full text
    Journal Article
  12. 12

    P-A2 Towards curtailing HIV latency by combinatorial unblocking viral transcription by Arya, Suresh, Holczbauer, Agnes

    “…The idea that it may be possible to "cure" AIDS is beginning to be accepted. Whether that is realistic or a pipe dream remains to be seen. The impediment is…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Increased Expression of Claudin-1 and Claudin-7 in Liver Cirrhosis and Hepatocellular Carcinoma by Holczbauer, Ágnes, Gyöngyösi, Benedek, Lotz, Gábor, Törzsök, Péter, Kaposi-Novák, Pál, Szijártó, Attila, Tátrai, Péter, Kupcsulik, Péter, Schaff, Zsuzsa, Kiss, András

    Published in Pathology oncology research (01-07-2014)
    “…Claudins have been reported to be differentially regulated in malignancies and implicated in the process of carcinogenesis and tumor progression. Claudin-1 has…”
    Get full text
    Journal Article
  17. 17

    MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities by Sequera, Célia, Grattarola, Margherita, Holczbauer, Agnes, Dono, Rosanna, Pizzimenti, Stefania, Barrera, Giuseppina, Wangensteen, Kirk, Maina, Flavio

    Published in Cell death & disease (24-11-2022)
    “…Abstract Enhanced activation of the transcription factor MYC and of the receptor tyrosine kinase MET are among events frequently occurring in hepatocellular…”
    Get full text
    Journal Article
  18. 18

    HIV Latency: Activating Virus Expression with Combined Genetic and Chemical Tools by Arya, Suresh K, Holczbauer, Agnes

    Published in Molecular therapy (01-09-2013)
    “…One difficulty in curing HIV/AIDS is the tendency of the virus to enter into latency, where minimal or no viral gene expression occurs. The sequestered virus…”
    Get full text
    Journal Article
  19. 19

    Epigenetic reprogramming modulates malignant properties of human liver cancer by Raggi, Chiara, Factor, Valentina M., Seo, Daekwan, Holczbauer, Agnes, Gillen, Matthew C., Marquardt, Jens U., Andersen, Jesper B., Durkin, Marian, Thorgeirsson, Snorri S.

    Published in Hepatology (Baltimore, Md.) (01-06-2014)
    “…Reversal of DNA hypermethylation and associated gene silencing is an emerging cancer therapy approach. Here we addressed the impact of epigenetic alterations…”
    Get full text
    Journal Article
  20. 20

    Down regulating HIV latency by transcription activation by Arya, Suresh K, Holczbauer, Agnes

    Published in Molecular therapy (01-09-2012)
    “…One difficulty in curing HIV/AIDS is the tendency of the virus to enter into latency, where minimal or no viral gene expression occurs. The sequestered virus…”
    Get full text
    Journal Article